Aspira Pathlab & Diagnostics Ltd — Updates, 08-04-2025: Company Update

Aspira Pathlab & Diagnostics Limited has announced a board meeting regarding a Writ Petition filed with the Bombay High Court for recovering outstanding fees of INR 1.06 crores from the Brihanmumbai Municipal Corporation (BMC) for diagnostic services provided during the COVID-19 pandemic. The petition seeks various directives for payment clearance and an expedited settlement. While the disputed amount is significant, management expects no material financial impact from the litigation's outcome. Investors may see this as a positive outlook, reflecting the company's proactive stance in addressing receivables and potential stabilization of cash flows.